IL-15/IL-15 receptor biology: a guided tour through an expanding universe.

[1]  A. Trumpp,et al.  c-Myc acts downstream of IL-15 in the regulation of memory CD8 T-cell homeostasis. , 2006, Blood.

[2]  E. Martı́n-Mola,et al.  Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. , 2006, Arthritis and rheumatism.

[3]  R. Paus,et al.  The interleukin‐15/interleukin‐15 receptor system as a model for juxtacrine and reverse signaling , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[4]  D. Gomez-Nicola,et al.  Regulation by GD3 of the proinflammatory response of microglia mediated by interleukin‐15 , 2006, Journal of neuroscience research.

[5]  P. Burkett,et al.  Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. , 2006, Annual review of immunology.

[6]  J. Grötzinger,et al.  The Structure of the Interleukin-15α Receptor and Its Implications for Ligand Binding* , 2006, Journal of Biological Chemistry.

[7]  R. Sun,et al.  Human Interleukin-15 Improves Engraftment of Human T Cells in NOD-SCID Mice , 2006, Clinical and Vaccine Immunology.

[8]  T. Warner,et al.  Anti-Interleukin-15 Prevents Arthritis in Borrelia-Vaccinated and -Infected Mice , 2006, Clinical and Vaccine Immunology.

[9]  A. Plet,et al.  Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins. , 2006, The Journal of biological chemistry.

[10]  T. Waldmann,et al.  Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  L. Klareskog,et al.  Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor , 2005, Arthritis research & therapy.

[12]  Z. Meng,et al.  Molecular characterization of woodchuck interleukin 15 (wIL-15) and detection of its expression in liver samples of woodchucks infected with woodchuck hepatitis virus (WHV). , 2005, Cytokine.

[13]  R. Paus,et al.  A promiscuous liaison between IL‐15 receptor and Axl receptor tyrosine kinase in cell death control , 2005, The EMBO journal.

[14]  R. González-Amaro,et al.  IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. , 2005, Rheumatology.

[15]  K. Garcia,et al.  Structure of the Quaternary Complex of Interleukin-2 with Its α, ß, and γc Receptors , 2005, Science.

[16]  B. Wierusz-Wysocka,et al.  IL-15 is elevated in serum patients with type 1 diabetes mellitus. , 2005, Diabetes research and clinical practice.

[17]  V. Almendro,et al.  Interleukin-15 decreases proteolysis in skeletal muscle: a direct effect. , 2005, International journal of molecular medicine.

[18]  C. Smith,et al.  Cloning and expression of rabbit interleukin-15. , 2005, Veterinary immunology and immunopathology.

[19]  Toshio Ogihara,et al.  Serum interleukin-15 concentration in patients with essential hypertension. , 2005, American journal of hypertension.

[20]  L. Lefrançois,et al.  The roles of interleukin-15 receptor α: Trans-presentation, receptor component, or both? , 2005 .

[21]  T. Waldmann,et al.  Survival adjustment of mature dendritic cells by IL-15. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Graeber,et al.  TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells , 2005, Nature Medicine.

[23]  J. Argilés,et al.  Interleukin‐15 stimulates adiponectin secretion by 3T3‐L1 adipocytes: Evidence for a skeletal muscle‐to‐fat signaling pathway , 2005, Cell biology international.

[24]  H. Renz,et al.  Blocking IL-15 Prevents the Induction of Allergen-Specific T Cells and Allergic Inflammation In Vivo , 2005, The Journal of Immunology.

[25]  J. Schertzer,et al.  Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice. , 2005, The American journal of pathology.

[26]  J. Grooten,et al.  IL-15 and IL-15Ralpha in CD4+T cell immunity. , 2005, Archivum immunologiae et therapiae experimentalis.

[27]  A. Douvdevani,et al.  Renal cells express a functional interleukin-15 receptor. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  N. Restifo,et al.  CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. , 2005, Journal of immunotherapy.

[29]  M. Tsai,et al.  Mast cells in the development of adaptive immune responses , 2005, Nature Immunology.

[30]  A. Barger,et al.  Cloning and expression of feline interleukin 15. , 2005, Cytokine.

[31]  T. Waldmann,et al.  Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. , 2005, Blood.

[32]  T. Yajima,et al.  A novel autoregulatory mechanism for transcriptional activation of the IL‐15 gene by a nonsecretable isoform of IL‐15 generated by alternative splicing , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  E. Cillari,et al.  Interleukin‐15, as Interferon‐gamma, Induces the Killing of Leishmania infantum in Phorbol‐Myristate‐Acetate‐Activated Macrophages Increasing Interleukin‐12 , 2004, Scandinavian journal of immunology.

[34]  Y. Choi,et al.  Follicular Dendritic Cells Produce IL-15 That Enhances Germinal Center B Cell Proliferation in Membrane-Bound Form1 , 2004, The Journal of Immunology.

[35]  Michelle M. Sandau,et al.  Cutting Edge: Transpresentation of IL-15 by Bone Marrow-Derived Cells Necessitates Expression of IL-15 and IL-15Rα by the Same Cells1 , 2004, The Journal of Immunology.

[36]  Dolca Thomas,et al.  Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Strom,et al.  Targeting IL-15 Receptor-Bearing Cells with an Antagonist Mutant IL-15/Fc Protein Prevents Disease Development and Progression in Murine Collagen-Induced Arthritis1 , 2004, The Journal of Immunology.

[38]  H. Shimauchi,et al.  Endogenous IL-15 Sustains Recruitment of IL-2Rβ and Common γ and IL-2-Mediated Chemokine Production in Normal and Inflamed Human Gingival Fibroblasts1 , 2004, The Journal of Immunology.

[39]  R. Silverman,et al.  Reverse Signaling through Membrane-bound Interleukin-15* , 2004, Journal of Biological Chemistry.

[40]  N. Iizuka,et al.  Tumor secreting high levels of IL-15 induces specific immunity to low immunogenic colon adenocarcinoma via CD8+ T cells. , 2004, International journal of molecular medicine.

[41]  Walter Kolch,et al.  Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. , 2004, Cytokine & growth factor reviews.

[42]  S. Rose-John,et al.  Natural Soluble Interleukin-15Rα Is Generated by Cleavage That Involves the Tumor Necrosis Factor-α-converting Enzyme (TACE/ADAM17)* , 2004, Journal of Biological Chemistry.

[43]  A. Plet,et al.  Natural, Proteolytic Release of a Soluble Form of Human IL-15 Receptor α-Chain That Behaves as a Specific, High Affinity IL-15 Antagonist1 , 2004, The Journal of Immunology.

[44]  T. Waldmann,et al.  IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Martı́n-Mola,et al.  IL-15 and the Initiation of Cell Contact-Dependent Synovial Fibroblast-T Lymphocyte Cross-Talk in Rheumatoid Arthritis: Effect of Methotrexate1 , 2004, The Journal of Immunology.

[46]  D. Girard,et al.  Interleukin‐15 enhances human neutrophil phagocytosis by a Syk‐dependent mechanism: importance of the IL‐15Rα chain , 2004, Journal of leukocyte biology.

[47]  T. Waldmann.  Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases , 2004, Arthritis research & therapy.

[48]  Yannick Jacques,et al.  Identification of an Interleukin-15α Receptor-binding Site on Human Interleukin-15* , 2004, Journal of Biological Chemistry.

[49]  D. Girard,et al.  Interleukin‐15 delays human neutrophil apoptosis by intracellular events and not via extracellular factors: role of Mcl‐1 and decreased activity of caspase‐3 and caspase‐8 , 2004, Journal of leukocyte biology.

[50]  P. Colarusso,et al.  Monocyte Surface-Bound IL-15 Can Function as an Activating Receptor and Participate in Reverse Signaling1 , 2004, The Journal of Immunology.

[51]  Rafał Kamiński,et al.  Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice , 2004, Cancer Immunology, Immunotherapy.

[52]  K. Ajuwon,et al.  Interleukin-6 and interleukin-15 are selectively regulated by lipopolysaccharide and interferon-gamma in primary pig adipocytes. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[53]  Sung-Hwan Park,et al.  Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts. , 2004, Arthritis and rheumatism.

[54]  L. Lefrançois,et al.  Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells. , 2004, Blood.

[55]  J. Banchereau,et al.  Dendritic cells generated in the presence of GM‐CSF plus IL‐15 prime potent CD8+ Tc1 responses in vivo , 2004, European journal of immunology.

[56]  D. Foster,et al.  Interleukin-21 inhibits dendritic cell activation and maturation. , 2003, Blood.

[57]  R. Paus,et al.  Dendritic cell‐derived IL‐15 controls the induction of CD8 T cell immune responses , 2003, European journal of immunology.

[58]  N. Hayashi,et al.  Autocrine/Paracrine IL-15 That Is Required for Type I IFN-Mediated Dendritic Cell Expression of MHC Class I-Related Chain A and B Is Impaired in Hepatitis C Virus Infection 1 , 2003, The Journal of Immunology.

[59]  P. Parren,et al.  Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. , 2003, The Journal of clinical investigation.

[60]  A. Signore,et al.  Reduced cumulative incidence of diabetes but not insulitis following administration of chimeric human IL‐15–murine IgG2b in NOD mice , 2003, Diabetes/metabolism research and reviews.

[61]  M. Zago,et al.  The Profile of Gene Expression of Human Marrow Mesenchymal Stem Cells , 2003, Stem cells.

[62]  Kazuhiro Yoshida,et al.  Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[63]  M. Harnett,et al.  New strategies to control inflammatory synovitis: interleukin 15 and beyond , 2003, Annals of the rheumatic diseases.

[64]  L. S. Quinn,et al.  Interleukin‐15 increases myosin accretion in human skeletal myogenic cultures , 2003, Cell biology international.

[65]  P. Musiani,et al.  Tumor Cells Engineered with IL-12 and IL-15 Genes Induce Protective Antibody Responses in Nude Mice1 , 2003, The Journal of Immunology.

[66]  C. C. Mok,et al.  Pathogenesis of systemic lupus erythematosus , 2003, Journal of Clinical Pathology.

[67]  R. Paus,et al.  Mast Cells Express Novel Functional IL-15 Receptor α Isoforms1 , 2003, The Journal of Immunology.

[68]  P. Ricciardi-Castagnoli,et al.  Early IL-2 Production by Mouse Dendritic Cells Is the Result of Microbial-Induced Priming1 , 2003, The Journal of Immunology.

[69]  P. Burkett,et al.  IL-15Rα expression on CD8+ T cells is dispensable for T cell memory , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Simi Ali,et al.  Tubulitis in renal allograft rejection: role of transforming growth factor-&bgr; and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells1 , 2003, Transplantation.

[71]  M. Fujimoto,et al.  Interleukin 15 induces the signals of epidermal proliferation through ERK and PI 3-kinase in a human epidermal keratinocyte cell line, HaCaT. , 2003, Biochemical and biophysical research communications.

[72]  C. Mathieu,et al.  IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice , 2003, Diabetologia.

[73]  J. Kirby,et al.  Post‐Transplant Renal Tubulitis: The Recruitment, Differentiation and Persistence of Intra‐Epithelial T Cells , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[74]  M. Pelletier,et al.  Mechanisms involved in interleukin‐15‐induced suppression of human neutrophil apoptosis: role of the anti‐apoptotic Mcl‐1 protein and several kinases including Janus kinase‐2, p38 mitogen‐activated protein kinase and extracellular signal‐regulated kinases‐1/2 , 2002, FEBS letters.

[75]  P. Burkett,et al.  Regulation of lymphoid homeostasis by interleukin-15. , 2002, Cytokine & growth factor reviews.

[76]  Fooyew Liew,et al.  Role of interleukin 15 and interleukin 18 in inflammatory response , 2002, Annals of the rheumatic diseases.

[77]  T. Waldmann,et al.  IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells , 2002 .

[78]  S. Thornton,et al.  Interleukin-15 inhibits sodium nitroprusside-induced apoptosis of synovial fibroblasts and vascular endothelial cells. , 2002, Arthritis and rheumatism.

[79]  J. Argilés,et al.  Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. , 2002, Experimental cell research.

[80]  T. Strom,et al.  Fibroblast-Like Synoviocytes from Rheumatoid Arthritis Patients Express Functional IL-15 Receptor Complex: Endogenous IL-15 in Autocrine Fashion Enhances Cell Proliferation and Expression of Bcl-xL and Bcl-21 , 2002, The Journal of Immunology.

[81]  N. Kamatani,et al.  Increased IL-15 production of muscle cells in polymyositis and dermatomyositis. , 2002, International immunology.

[82]  T. Roszman,et al.  Differential localization of IL‐2‐ and ‐15 receptor chains in membrane rafts of human T cells , 2002, Journal of leukocyte biology.

[83]  M. Bertolotto,et al.  Differential regulation of spontaneous and immune complex‐induced neutrophil apoptosis by proinflammatory cytokines. Role of oxidants, Bax and caspase‐3 , 2002, Journal of leukocyte biology.

[84]  D. Maślińska,et al.  Expression of IL‐15 and IL‐15 Receptor Isoforms in Select Structures of Human Fetal Brain , 2002, Annals of the New York Academy of Sciences.

[85]  F. Moosig,et al.  Peripheral Blood and Granuloma CD4+CD28− T Cells Are a Major Source of Interferon-γ and Tumor Necrosis Factor-α in Wegener’s Granulomatosis , 2002 .

[86]  C. Jasmin,et al.  Fibroblasts from Human Spleen Regulate NK Cell Differentiation from Blood CD34+ Progenitors Via Cell Surface IL-151 , 2002, The Journal of Immunology.

[87]  S. Wenzel,et al.  Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation. , 2002, American journal of respiratory cell and molecular biology.

[88]  D. Salant,et al.  IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. , 2002, The Journal of clinical investigation.

[89]  F. López‐Soriano,et al.  Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue. , 2002, Biochimica et biophysica acta.

[90]  M. Aringer,et al.  Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death , 2002, Lupus.

[91]  S. Koyasu,et al.  Critical role of IL-15–IL-15R for antigen-presenting cell functions in the innate immune response , 2001, Nature Immunology.

[92]  R. Paus,et al.  The IL-15Rα Chain Signals Through Association with Syk in Human B Cells1 , 2001, The Journal of Immunology.

[93]  W. Leonard.  Cytokines and immunodeficiency diseases , 2001, Nature Reviews Immunology.

[94]  S. Muro,et al.  Expression of IL-15 in inflammatory pulmonary diseases. , 2001, The Journal of allergy and clinical immunology.

[95]  H. Yokozaki,et al.  Interleukin-15 Expression Is Associated with Malignant Potential in Colon Cancer Cells , 2001, Pathobiology.

[96]  R. Dummer,et al.  Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. , 2001, Blood.

[97]  H. Wong,et al.  Lipopolysaccharide-Stimulated or Granulocyte-Macrophage Colony-Stimulating Factor-Stimulated Monocytes Rapidly Express Biologically Active IL-15 on Their Cell Surface Independent of New Protein Synthesis1 2 , 2001, The Journal of Immunology.

[98]  J. Banchereau,et al.  Interleukin 15 Skews Monocyte Differentiation into Dendritic Cells with Features of Langerhans Cells , 2001, The Journal of experimental medicine.

[99]  T. Strom,et al.  An Antagonist IL-15/Fc Protein Prevents Costimulation Blockade-Resistant Rejection1 , 2001, The Journal of Immunology.

[100]  P. Eriksson,et al.  Expression of interleukin-15 in mouse and human atherosclerotic lesions. , 2001, The American journal of pathology.

[101]  F. Belardelli,et al.  IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation1 , 2001, The Journal of Immunology.

[102]  M. Aringer,et al.  Serum interleukin-15 is elevated in systemic lupus erythematosus. , 2001, Rheumatology.

[103]  A. Masuda,et al.  Interleukin-15 Prevents Mouse Mast Cell Apoptosis through STAT6-mediated Bcl-xL Expression* , 2001, The Journal of Biological Chemistry.

[104]  I. McInnes,et al.  The Sushi Domain of Soluble IL-15 Receptor α Is Essential for Binding IL-15 and Inhibiting Inflammatory and Allogenic Responses In Vitro and In Vivo1 , 2001, The Journal of Immunology.

[105]  A. Moorman,et al.  Interleukin-15 Expression in Atherosclerotic Plaques: An Alternative Pathway for T-Cell Activation in Atherosclerosis? , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[106]  F. López‐Soriano,et al.  Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. , 2001, Biochimica et biophysica acta.

[107]  Kazuto Ito,et al.  NK cell‐mediated anti‐tumor immune response to human prostate cancer cell, PC‐3: immunogene therapy using a highly secretable form of interleukin‐15 gene transfer , 2001, Journal of leukocyte biology.

[108]  A. Douvdevani,et al.  CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES. , 2001, Journal of the American Society of Nephrology : JASN.

[109]  W. Leonard.  Role of Jak Kinases and STATs in Cytokine Signal Transduction , 2001, International journal of hematology.

[110]  A. Ullrich,et al.  Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission , 2001, Oncogene.

[111]  Y. Morita,et al.  Effector Function of Resting T Cells: Activation of Synovial Fibroblasts1 , 2001, The Journal of Immunology.

[112]  A. Gaggero,et al.  IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα , 2000, Oncogene.

[113]  B. Neel,et al.  New Role for Shc in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway , 2000, Molecular and Cellular Biology.

[114]  T. Waldmann,et al.  The Long Signal Peptide Isoform and Its Alternative Processing Direct the Intracellular Trafficking of Interleukin-15* , 2000, The Journal of Biological Chemistry.

[115]  M. Kubo,et al.  Interleukin-15 Induces Rapid Tyrosine Phosphorylation of STAT6 and the Expression of Interleukin-4 in Mouse Mast Cells* , 2000, The Journal of Biological Chemistry.

[116]  J. Bradley,et al.  Selective Blockade of IL-15 by Soluble IL-15 Receptor α-Chain Enhances Cardiac Allograft Survival1 , 2000, The Journal of Immunology.

[117]  K. Asadullah,et al.  Inhibition of Keratinocyte Apoptosis by IL-15: A New Parameter in the Pathogenesis of Psoriasis?1 , 2000, The Journal of Immunology.

[118]  P. Musiani,et al.  Gene transfer of a secretable form of IL‐15 in murine adenocarcinoma cells: Effects on tumorigenicity, metastatic potential and immune response , 2000, International journal of cancer.

[119]  J. Mascola,et al.  Eosinophilia with aberrant T cells and elevated serum levels of interleukin-2 and interleukin-15. , 2000, The New England journal of medicine.

[120]  T. Matsuguchi,et al.  Differences in interleukin-12 and -15 production by dendritic cells at the early stage of Listeria monocytogenes infection between BALB/c and C57 BL/6 mice. , 2000, Cellular immunology.

[121]  M. Cassatella,et al.  Interleukin-15 and its impact on neutrophil function , 2000, Current opinion in hematology.

[122]  G. Hommel,et al.  Interleukin-7 or Interleukin-15 Enhances Survival of Mycobacterium tuberculosis-Infected Mice , 2000, Infection and Immunity.

[123]  Paul Rutgeerts,et al.  IL-15 Is Highly Expressed in Inflammatory Bowel Disease and Regulates Local T Cell-Dependent Cytokine Production1 , 2000, The Journal of Immunology.

[124]  P. Morrissey,et al.  Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.

[125]  Hiroshi Yamamoto,et al.  Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene , 2000, Cancer Gene Therapy.

[126]  R. Greil,et al.  Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma. , 2000, Blood.

[127]  P. Ohashi,et al.  Differential Roles of Interleukin 15 mRNA Isoforms Generated by Alternative Splicing in Immune Responses in Vivo , 2000, The Journal of experimental medicine.

[128]  F. Magrangeas,et al.  Natural Splicing of Exon 2 of Human Interleukin-15 Receptor α-Chain mRNA Results in a Shortened Form with a Distinct Pattern of Expression* , 1999, The Journal of Biological Chemistry.

[129]  R. Paus,et al.  Death deflected: IL‐15 inhibits TNF‐α‐mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL‐15Rα chain , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[130]  M. Mohamadzadeh,et al.  Interleukin 15 Induces Endothelial Hyaluronan Expression in Vitro and Promotes Activated T Cell Extravasation through a Cd44-Dependent Pathway in Vivo , 1999, The Journal of experimental medicine.

[131]  S. Targan,et al.  Current theories on the causes of inflammatory bowel disease. , 1999, Gastroenterology clinics of North America.

[132]  A. Erdei,et al.  Interleukin-15 Enhances HIV-1-Driven Polyclonal B-Cell Response in vitro , 1999, Experimental and Clinical Immunogenetics.

[133]  M. Zucca,et al.  Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. , 1999, Blood.

[134]  A. Gaggero,et al.  Differential intracellular trafficking, secretion and endosomal localization of two IL‐15 isoforms , 1999, European journal of immunology.

[135]  K. Choi,et al.  Molecular and functional characterization of chickenIL-15 , 1999 .

[136]  M. Russo,et al.  Interleukin-15 (IL-15) Induces NF-κB Activation and IL-8 Production in Human Neutrophils , 1998 .

[137]  F. Kirchhoff,et al.  Alternative splicing of mouse IL-15 is due to the use of an internal splice site in exon 5. , 1998, Brain research. Molecular brain research.

[138]  W. Leonard,et al.  Stat5b Is Essential for Natural Killer Cell–mediated Proliferation and Cytolytic Activity , 1998, The Journal of experimental medicine.

[139]  T. Dassopoulos,et al.  IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. , 1998, Immunity.

[140]  J. Marshall,et al.  The IL-1β-Converting Enzyme (Caspase-1) Inhibits Apoptosis of Inflammatory Neutrophils Through Activation of IL-1β , 1998, The Journal of Immunology.

[141]  R. Dummer,et al.  Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. , 1998, Blood.

[142]  A. Douvdevani,et al.  Interleukin-15, a leukocyte activator and growth factor, is produced by cortical tubular epithelial cells. , 1998, Journal of the American Society of Nephrology : JASN.

[143]  Y. S. Kim,et al.  Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. , 1998, Journal of immunology.

[144]  Y. Yoshikai,et al.  Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. , 1998, Gastroenterology.

[145]  I. McInnes,et al.  Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. , 1998, Journal of immunology.

[146]  R. Badolato,et al.  Interleukin-15 Activates Proinflammatory and Antimicrobial Functions in Polymorphonuclear Cells , 1998, Infection and Immunity.

[147]  Michael P. Brown,et al.  Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[148]  J. Ritz,et al.  IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops , 1998, Oncogene.

[149]  T. Waldmann,et al.  The 5' untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control. , 1998, Journal of immunology.

[150]  K. Lundin,et al.  Cytokine profiles of cultured microvascular endothelial cells from the human intestine , 1998, Gut.

[151]  T. Mak,et al.  The Transcription Factor Interferon Regulatory Factor 1 (IRF-1) Is Important during the Maturation of Natural Killer 1.1+ T Cell Receptor–α/β+ (NK1+ T) Cells, Natural Killer Cells, and Intestinal Intraepithelial T Cells , 1998, The Journal of experimental medicine.

[152]  R. Brezinschek,et al.  Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. , 1998, The Journal of clinical investigation.

[153]  J. Satoh,et al.  Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues , 1998, Journal of the Neurological Sciences.

[154]  T. Waldmann,et al.  Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site , 1998 .

[155]  S. Chanock,et al.  Interleukin-15 Augments Superoxide Production and Microbicidal Activity of Human Monocytes against Candida albicans , 1998, Infection and Immunity.

[156]  T. Waldmann,et al.  Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[157]  F. Kirchhoff,et al.  Mouse Brain Microglia Express Interleukin-15 and Its Multimeric Receptor Complex Functionally Coupled to Janus Kinase Activity* , 1997, The Journal of Biological Chemistry.

[158]  R. Paus,et al.  Interleukin-15 protects from lethal apoptosis in vivo , 1997, Nature Medicine.

[159]  L. Notarangelo,et al.  Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes , 1997 .

[160]  R. Zambello,et al.  Interleukin-15: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. , 1997, Leukemia & lymphoma.

[161]  J. Lunney,et al.  Molecular cloning of cDNA encoding porcine interleukin-15. , 1997, Gene.

[162]  T. Strom,et al.  Interleukin-15 signals T84 colonic epithelial cells in the absence of the interleukin-2 receptor beta-chain. , 1997, The American journal of physiology.

[163]  H. Kanegane,et al.  Interleukin-15 promotes angiogenesis in vivo. , 1997, Biochemical and biophysical research communications.

[164]  F. Breedveld,et al.  INCREASED EXPRESSION OF IL‐15 IN THE SYNOVIUM OF PATIENTS WITH RHEUMATOID ARTHRITIS COMPARED WITH PATIENTS WITH YERSINIA‐INDUCED ARTHRITIS AND OSTEOARTHRITIS , 1997, The Journal of pathology.

[165]  R. Paxton,et al.  Structure-Function Studies of Interleukin 15 using Site-specific Mutagenesis, Polyethylene Glycol Conjugation, and Homology Modeling* , 1997, The Journal of Biological Chemistry.

[166]  T. Pohl,et al.  Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. , 1997, Journal of immunology.

[167]  A. Beaulieu,et al.  Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15. , 1996, Blood.

[168]  T. Waldmann,et al.  Identification of a novel receptor/signal transduction pathway for IL‐15/T in mast cells , 1996, The EMBO journal.

[169]  O. Nielsen,et al.  Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. , 1996, The American journal of gastroenterology.

[170]  C. Wernicke,et al.  Genomic structure and chromosomal localization of the human interleukin 15 gene (IL-15). , 1996, Cytokine.

[171]  P. Carlson,et al.  Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. , 1996, Arthritis and rheumatism.

[172]  M. Colombo,et al.  Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. , 1996, Oncogene.

[173]  F. Rodeghiero,et al.  Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. , 1996, Blood.

[174]  J. Satoh,et al.  Interleukin‐15 gene expression in human astrocytes and microglia in culture , 1996, Neuroreport.

[175]  T. Waldmann,et al.  Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[176]  L. Flamand,et al.  Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. , 1996, The Journal of clinical investigation.

[177]  I. McInnes,et al.  The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis , 1996, Nature Medicine.

[178]  A. Sher,et al.  Induction and regulation of IL-15 expression in murine macrophages. , 1996, Journal of immunology.

[179]  N. Copeland,et al.  Functional Characterization of the Human Interleukin-15 Receptor αChain and Close Linkage of IL15RA and IL2RA Genes (*) , 1995, The Journal of Biological Chemistry.

[180]  W. Leonard,et al.  Role of the Common Cytokine Receptor γ Chain in Cytokine Signaling and Lymphoid Development , 1995, Immunological reviews.

[181]  P. Doherty,et al.  Defective Lymphoid Development in Mice Lacking Jak3 , 1995, Science.

[182]  R. Rees,et al.  Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[183]  T. Paavonen,et al.  Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. , 1995, Circulation.

[184]  R. Dubose,et al.  Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. , 1995, The EMBO journal.

[185]  K. Grabstein,et al.  Interleukin-15: a novel anabolic cytokine for skeletal muscle. , 1995, Endocrinology.

[186]  R. Perlmutter,et al.  Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation , 1995, Cell.

[187]  F. Liew,et al.  Chemoattraction of human blood T lymphocytes by interleukin-15 , 1995, The Journal of experimental medicine.

[188]  N. Copeland,et al.  Chromosomal assignment and genomic structure of Il15. , 1995, Genomics.

[189]  R. Paxton,et al.  IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. , 1995, Journal of immunology.

[190]  P. Familletti,et al.  Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival. , 1994, Journal of immunology.

[191]  M. Caligiuri,et al.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor , 1994, The Journal of experimental medicine.

[192]  D. Cosman,et al.  Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15. , 1994, The EMBO journal.

[193]  T. Waldmann,et al.  A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[194]  V. Fung,et al.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. , 1994, Science.

[195]  J. Fargnoli,et al.  Interleukin-2-induced tyrosine phosphorylation of Shc proteins correlates with factor-dependent T cell proliferation. , 1994, The Journal of biological chemistry.

[196]  D. Cosman.  The hematopoietin receptor superfamily. , 1993, Cytokine.

[197]  N. Tanaka,et al.  Cloning of the gamma chain of the human IL-2 receptor. , 1992, Science.

[198]  T. Taniguchi,et al.  Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. , 1989, Science.

[199]  C. Thompson,et al.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.

[200]  Robert B Sim,et al.  A study of the structure of human complement component factor H by Fourier transform infrared spectroscopy and secondary structure averaging methods. , 1988, Biochemistry.

[201]  S. O’Brien,et al.  Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1. , 1984, Science.

[202]  I. McInnes.  Cytokine Targeting in Psoriasis and Psoriatic Arthritis: Beyond TNFα , 2005 .

[203]  M. Caligiuri,et al.  Interleukin-2, interleukin-15, and their roles in human natural killer cells. , 2005, Advances in immunology.

[204]  Stefan Rose-John,et al.  Interleukin-6 biology is coordinated by membrane bound and soluble receptors. , 2003, Acta biochimica Polonica.

[205]  S. Ugurel,et al.  Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alpha. , 2001, The Journal of investigative dermatology.

[206]  M. Caligiuri,et al.  Interleukin 15: biology and relevance to human disease. , 2001, Blood.

[207]  B. Seliger,et al.  Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer. , 1999, International journal of oncology.

[208]  R. Dummer,et al.  Constitutive and Interleukin-7/Interleukin-15 Stimulated DNA Binding of Myc, Jun, and Novel Myc-Like Proteins in Cutaneous T-Cell Lymphoma Cells , 1999 .

[209]  T. Waldmann,et al.  The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. , 1999, Annual review of immunology.

[210]  尾形 善康.  A novel role of IL-15 in the development of osteoclasts : inability to replace its activity with IL-2 , 1999 .

[211]  H. Wekerle,et al.  Myelin specific, autoaggressive T cell clones in the normal immune repertoire: their nature and their regulation. , 1992, International reviews of immunology.

[212]  J. Bazan,et al.  Haemopoietic receptors and helical cytokines. , 1990, Immunology today.